期刊文献+

帕病2号方对帕金森病模型大鼠中脑黑质Nrf2,HO-1表达的影响 被引量:8

Research on Expressions of Nrf2 and HO-1 in Substantia Nigra of Rats with Parkinson Disease Treated with Pabing 2 Formula
原文传递
导出
摘要 目的:观察帕病2号方对6-羟基多巴胺(6-OHDA)所致帕金森病(PD)大鼠中脑黑质组织内核因子E2相关性因子2(Nrf2)以及下游靶基因血红加氧酶1(HO-1)的表达。方法:采用6-OHDA左侧纹状体两点注射法建立PD大鼠模型,经阿卟吗啡(APO)诱导表现为恒定右侧旋转且旋转圈数大于210 r·30 min-1视为成功PD大鼠模型。24只造模成功大鼠随机分为模型组,帕病2号方低、中、高剂量组(8.0,16.0,32.0 g·kg-1),同时设立正常组,假手术组。正常组,假手术组,模型组给予等容积蒸馏水,连续灌胃给药4周。Western blot法检测中脑黑质Nrf2细胞核蛋白及HO-1蛋白表达。RT-PCR法检测中脑黑质Nrf2,HO-1mRNA表达。结果:与假手术组比较,模型组Nrf2细胞核蛋白,HO-1蛋白表达上调(P<0.01),Nrf2,HO-1mRNA水平上调(P<0.01);与模型组比较,帕病2号方低、中、高剂量组大鼠中脑黑质组织Nrf2细胞核蛋白,HO-1蛋白表达明显上调(P<0.01),Nrf2,HO-1mRNA水平上调(P<0.01),帕病2号方高剂量组与中、低剂量组比较有明显差异(P<0.01)。结论:6-OHDA造模后可以激活Nrf2/HO-1信号通路;帕病2号方治疗后进一步提高Nrf2细胞核蛋白和Nrf2mRNA表达,进而上调下游靶基因HO-1蛋白及HO-1mRNA的表达,且帕病2号方高剂量组作用更为明显。 Objective:To investigate the effect of Pabing 2 formula on the expression of nuclear factor E2-related factor 2 (Nrf2) and the hemeoxygenasel (HO-1) in substantia nigra tissue of Parkinson disease (PD) rats model induced by 6-hydroxydopamine (6-OHDA).Method:The rats were stereotaxically injected with 6-OHDA solution into the left striatum in two-site.Rats showed consistently right whirling and the number of rotation was more than 210 r ·30 min-1 induced by APO,then the rat was judged as PD model.Twenty-four modeling rats successfully were randomly divided into four groups:model group,Pabing 2 formula (8.0,16.0,32.0 g · kg-1),at the same time,the normal group and sham group were established and given distilled water at the same volume,all with a course of 4 weeks.The nuclear Nrf2 protein and HO-1 protein levels of the substantia nigra tissue were detected by Western blot,and the mRNA levels of Nrf2 and HO-1 were determined with RT-PCR.Result:Compared with sham group,the nuclear Nrf2 protein and HO-1 protein in substantia nigra tissue were significant increased (P < 0.01),and the mRNA levels of Nrf2 and HO-1 were increased in model group (P < 0.01).Compared with model group,the nuclear Nrf2 protein and HO-1 protein in substantia nigra tissue were significantly increased (P < 0.01),and the mRNA levels of both Nrf2 and HO-1were also upregulated in Pabing 2 formula low dose group,media dose group and high dose group (P < 0.01),Pabing 2 formula high dose group were significantly differences compared with the low dose group and media dose group (P <0.01).Conclusion:After 6-OHDA injection,the Nrf2/HO-1 signal transduction pathway is activated.Pabing 2 formula can enhance antioxidation ability.The underlying mechanism might be associated with activating Nrf2/HO-1 signal transduction pathway,promoting the nuclear Nrf2 protein and Nrf2 mRNA,then advancing the expression of antioxidant gene in the downstream such as HO-1 protein and HO-1 mRNA.The effects were more obvious in Pabing 2 formula high dose group.
出处 《中国实验方剂学杂志》 CAS 北大核心 2014年第8期158-162,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 广东省中医药管理局项目(20132150)
关键词 帕病2号方 帕金森病 核因子E2相关性因子2 血红加氧酶1 Pabing 2 formula Parkinson disease Nrf2 HO-1
  • 相关文献

参考文献17

  • 1陆建明,周厚广,鲍远程,尤年兴,薛建中.左旋多巴对帕金森病大鼠毒性作用的实验研究[J].临床神经病学杂志,2004,17(5):354-356. 被引量:6
  • 2郑春叶,雒晓东,孙玉芝,吴薇,王文同.中医辨证治疗帕金森病进展述评[J].新中医,2004,36(1):73-75. 被引量:8
  • 3范宇鹏,曾亮,孙玉芝,苏巧珍,连新福.帕病2号方治疗震颤型帕金森病的临床研究[J].天津中医药,2010,27(3):190-191. 被引量:26
  • 4文晓东,雒晓东,王春玲.帕病2号方对帕金森病大鼠的保护作用[J].中国实验方剂学杂志,2012,18(9):224-228. 被引量:11
  • 5GEORGE PAXINOS.CHARLES WATSON.大鼠脑立体定位图谱[M].3版.北京:人民卫生出版社,2005:21.
  • 6Miller Rebecca L, James-Kracke Marilyn, Sun Grace Y, et al. Oxidative and inflammatory pathways in Parkinson' s disease [ J]. Neurochem Res, 2009, 34 (1) :55.
  • 7Satoh Takumi, Lipton Stuart A. Redox regulation of neuronal survival mediated by eleetrophilie compounds [J]. Trends Neurosci, 2007, 30(1):37.
  • 8Innamorato N G, Rojo A I, Garcia-Yagtie tJ, et al. The transcription factor Nrf2 is a therapeutic target against brain inflammation [ J ]. J Immunol, 2008, 181 (1) :680.
  • 9Ramsey Chenere P, Glass Charles A, Montgomery Marshall B, et al. Expression of Nrf2 in neurodegenerative diseases [ J ]. J Neuropathol Exp Neurol, 2007, 66( 1 ) :75.
  • 10Jakel R J, Townsend J A, Kraft A D, et al. Nrf2- mediated protection against 6-hydroxydopamine [ J ]. Brain Res, 2007, 1144 : 192.

二级参考文献66

共引文献71

同被引文献79

  • 1蒋诗媛.龟羚帕安丸治疗帕金森病30例[J].辽宁中医药大学学报,2009,11(4):118-119. 被引量:6
  • 2陈生弟.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:104
  • 3功能性胃肠病罗马Ⅲ诊断标准[J].胃肠病学,2006,11(12):761-765. 被引量:762
  • 4章元沛.药理学实验[M].北京:人民卫生出版社,1996.1.
  • 5GEORGE PAXINOS.CHARLES WATSON.大鼠脑立体定位图谱[M].3版.北京:人民卫生出版社,2005:21.
  • 6Mehndiratta M, Garg RK, Pandey S. Nonmotor symptom complex of Parkinson' s disease-an under-recognized entity [ J 3. J Assoc Physicians India, 2011,59 : 8302-8313.
  • 7Remy P, Doder M, Lees A, et al. Depression in Parkinson's disease loss of dopamine and noradrenaline innervation in the limbic system [J]. Brain, 2005,128(6) : 1314-1322.
  • 8Thobois S, Ardouin C, Lhommee E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson' s disease: predictors and underlying mesolimbic denervation [J]. Brain, 2010, 133(4) : 1111-1127.
  • 9Ravina B, Camicioli R, Come P G, et al. The impact ofdepressive symptoms in early Parkinson disease [J].Neurology, 2007, 69: 342.
  • 10Bramham C R, Messaoudi E P. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis [J]. Neurobiol, 2005, 76(2): 99.

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部